HCW Biologics (HCWB) Current Assets (2020 - 2025)
Historic Current Assets for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $1.6 million.
- HCW Biologics' Current Assets fell 2414.93% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 2414.93%. This contributed to the annual value of $5.7 million for FY2024, which is 1101.94% down from last year.
- Latest data reveals that HCW Biologics reported Current Assets of $1.6 million as of Q3 2025, which was down 2414.93% from $2.9 million recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Current Assets ranged from a high of $43.6 million in Q3 2021 and a low of $1.6 million during Q3 2025
- In the last 5 years, HCW Biologics' Current Assets had a median value of $11.9 million in 2021 and averaged $17.9 million.
- As far as peak fluctuations go, HCW Biologics' Current Assets skyrocketed by 24468.65% in 2022, and later plummeted by 8794.99% in 2024.
- HCW Biologics' Current Assets (Quarter) stood at $40.5 million in 2021, then decreased by 15.83% to $34.1 million in 2022, then crashed by 81.2% to $6.4 million in 2023, then fell by 11.02% to $5.7 million in 2024, then plummeted by 72.12% to $1.6 million in 2025.
- Its Current Assets was $1.6 million in Q3 2025, compared to $2.9 million in Q2 2025 and $1.9 million in Q1 2025.